“Tissue-Engineered ‘Metastases’: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist ”, J. Can. Res. Updates, vol. 1, no. 1, pp. 69–77, Aug. 2021, doi: 10.6000/1929-2279.2012.01.01.11.